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UNMHSC Plan to Move Toward Full Research
and Laboratory Activities – Initial Phase
During the COVID-19 pandemic and resulting shelter in place order, many non-essential
research projects and laboratory activities were paused. Subsequent to June 1, UNM will move
from our current state of limited operations to our initial phase of our movement toward full
operations. For this initial phase, we will allow increased activity but not a full reopening. Cloth
face coverings are mandatory in all Health Sciences Center common spaces. Buildings will
remain mostly locked.
The Health Sciences Center Office of Research website contains information on specific
research-related updates, including the Research Continuity Guidelines for both Laboratories &
Research Facilities and Clinical Trial Research Faculty & Staff.
We understand what a difficult time this has been for all, and the importance of the research
that is conducted at UNMHSC. We are working hard to identify and address challenges to the
conduct of research while protecting our patients, faculty and staff. Thank you for your
cooperation and support.

A Message from the Executive Vice Chancellor
and Vice Chancellor for Research
In order to ensure the safety of the UNMHSC laboratory and research communities, Safety
Officers from the Office of Research will conduct routine inspections of each lab. Faculty, staff

or BSGP graduate students may not return to work until their laboratories are cleared by
inspection as indicated below.
For research activity that is continuing subsequent to June 1, please follow COVID-19
Safe Practices
•

Limit operations to remote work to the greatest extent possible.

•

Arrange workplaces to provide for a minimum of 6 feet of distance between individuals.

•

Close common areas where personnel are likely to congregate wherever possible
or modify them to minimize contact.

•

Provide for all meetings to take place remotely whenever possible. Education-related
meetings such as dissertation defenses will follow the education return to work plan
and timeline.

•

Cover your mouth and nose with a face mask when around others and when moving
through common spaces. Follow all PPE required by OSHA when in a laboratory (see
instruction below). Wash your hands often with soap and water for at least 20 seconds.
Routinely and regularly disinfect common contact sites (keyboards, door handles, multiuser equipment, etc.).

•

For BSL-2 and BSL-3 work, please follow the PPE requirements for these activities.

•

All employees will be provided with appropriate face coverings or provide their own
prior to returning to work. Masks must be worn in the workplace.

•

Train all employees on daily cleaning and disinfecting protocol, hygiene, and
respiratory etiquette (e.g., covering coughs).

•

Make handwashing, sanitizer, and other hygiene support available to employees.

•

Prohibit employees with known close contact to a person who is lab-confirmed to have
COVID-19 to return to work until the end of the 14-day self-isolation period.

Physical Distancing in the Laboratory and Research Spaces
•

Only personnel with a need to access physical locations to advance research should be
on-site. This may include faculty, staff, or biomedical sciences graduate program
students.

•

Other students should not be working in laboratories.

•

Even personnel permitted should minimize time on campus.

•

All others should remain sheltered-in-place and/or off-site to help maintain physical
distancing. Meetings should be conducted remotely whenever possible. Supervisors
are encouraged to continue to accommodate telecommuting schedules with Tier 2

employees, especially those who are immune-suppressed or whose childcare options
are not yet available.
•

Labs may not be authorized for access unless the following parameters are defined
and readily available upon request to the Biosafety Officers. The PI in conjunction with
the appropriate Dean, Cancer Center Director, Clinical and Translational Science
Center Director or Vice Chancellor for Research who may have responsibility for the
space will be responsible for assuring that no one accesses laboratory space until it is
inspected. In addition, the same individuals are responsible for assuring and providing
the following during their laboratory inspection:

•

How many individuals will be in a space at any given time. Shift work will be necessary
if social distancing requirements cannot be met.

•

If necessary, a clear process to ensure work shifts do not accidentally overlap if 6 feet
between people cannot be maintained during a normal working situation.

•

A list of supplies provided to maintain safety and their storage location: face coverings,
soap, hand sanitizers, cleaning materials, first aid kits.

•

Procedures and schedule to clean/wipe down shared items, equipment, carts, and work
surfaces prior to usage by others. Consult the EPA List N for approved disinfectants
against SARS-CoV-2 (COVID-19).

•

A written process to maintain access and activity logs, either electronically or manually,
in order to trace contact should someone become sick with coronavirus.

•

Physical distance between people should always be maintained.

•

Maintain a distance of at least 6 feet between people unless PPE appropriate for the
context is used. Cloth face masks are not PPE.

•

Laboratories and facilities with limited space that cannot ensure personnel will meet
these public health requirements must remain off-limits.

•

Some locations may choose to reconfigure interior space to relieve bottlenecks and
maintain space between research personnel.

•

Do not gather in groups of size more than what is limited by county officials. Research
ramp-up should not result in crowded spaces or mass gatherings.

•

Cover your mouth and nose with a face mask when around others and when moving
through common spaces. Follow all PPE required by OSHA when in a laboratory (see
instruction below). Wash your hands often with soap and water for at least 20 seconds.
Routinely and regularly disinfect common contact sites (keyboards, door handles, multiuser equipment, etc.).

•

For BSL-2 and BSL-3 work, please follow the PPE requirements for these activities.

•

Employees will receive an email attestation each day to verify that they do not have
symptoms of any type of sickness. Symptomatic individuals should not come to work. If
a person becomes symptomatic while at work, immediately send them to Employee
and Occupational Heath, since they may or may not be COVID-19 positive. Depending
on the nature of the employee’s illness, they may be triaged to the Respiratory Care
Center.

•

Prohibit employees with known close contact to a person who is lab-confirmed to have
COVID-19 to return to work until the end of the 14-day self-isolation period.

•

Laboratories who do not meet and maintain COVID-19 Safe practices may lose their
ability to operate.

Required Cleaning Procedures
•

Decontaminate work surfaces and equipment with appropriate disinfectants. Use EPAregistered and approved disinfectants.

•

Disinfectants should be used with label claims to be effective against SARS-CoV2. Follow manufacturer’s recommendations for use, such as dilution, contact time, and
safe handling. For example, you may use EPA registered disinfectants that contain
10% bleach solutions (0.5% sodium hypochlorite), ethanol /quaternary ammonium
or > 0.5 hydrogen peroxide.

•

Notify BHC (TMuller@salud.unm.edu or NDonart@salud.unm.edu) if you are utilizing
another disinfectant, so a check of the disinfectant’s active ingredients can be
evaluated.

•

Note: IBC/BHC approval is required to work directly with SARS-CoV-2 or
known/suspected SARS-CoV-2 samples. All faculty and laboratory managers must
ensure their personnel are using aseptic techniques when processing specimens. This
includes disinfection of all surfaces and equipment using EPA registered
disinfectants that contain 10% bleach solutions (0.5% sodium hypochlorite), ethanol
/quaternary ammonium or > 0.5 hydrogen peroxide, both inside and outside of the
biosafety cabinet.

•

BSC surfaces must be rinsed with water 70% isopropanol after applying bleach to
prevent metal corrosion.

•

All manipulation of potentially infectious materials must be performed in certified
biosafety cabinets, per standard BSL-2 or BSL-3 requirements or as approved by
institutional biosafety committee or biosafety officer.

Required Personal Protective Equipment
•

Please refer to the CDC video demonstration of cleaning procedures as well as
donning (putting on) personal protective equipment (PPE). This video will be updated
with a CITI training video when available.

•

In addition to wet labs and research environments, masks must always be worn in
common areas and open labs. All personnel will have to provide their own cloth mask
that meets CDC requirements, until the HSC receives a shipment of cloth masks.

•

Per OSHA requirements and biosafety policies, all lab staff should have dedicated PPE
within your laboratory for your experiments, including lab coats and appropriate facial
protection.

•

Per UNMHSC Biosafety Training for BSL-1 and BSL-2 laboratories, do not wear PPE
(other than masks) outside of the non-lab areas.

•

Depending on the number of labs you have and the nature of the work, researchers
may need multiple lab coats for each area to avoid potential cross contamination.

•

Wear a lab coat or solid-front back-fastening gown, preferably with a knit or grip cuff.

•

For BSL-2 and BSL-3 activity, coverage of the wrists is very important. Avoid using an
open-cuff lab coat inside a biosafety cabinet, as aerosols generated inside the cabinet
will contaminate your jewelry, wrists, and forearms, as well as the inside of the lab coat
cuff.

•

For BSL-2 activity, ensure that your gloves extend over the sleeve of your lab coat. An
opening at the wrist will allow aerosols generated within the biosafety cabinet to
contaminate your wrist and forearm, extending to your elbow.

•

Sleeve covers can be worn to ensure coverage of the wrist and will also minimize
contamination of the sleeves of your lab coat.

•

Each person in the lab should have their own pair of safety glasses. These can be
sanitized after each use with 70% isopropanol and allowed to air dry.

•

Wear a chin-length face shield or safety glasses and a mask if working outside of the
biosafety cabinet with biohazards on the bench. This will protect the researcher’s facial
mucous membranes from exposure, in the event of a spill outside the biosafety cabinet
during transfer of material to and from the incubator.

•

Each person in the lab should have their own cloth face covering.

•

N95 masks and other high demand PPE must be used only when appropriate and
required for the laboratory environment and experiment.

•

Cloth face coverings should be sanitized often. This can be accomplished by machine
washing.

•

Except for masks, remove PPE before leaving the laboratory. Placing a hook within the
lab area will facilitate this requirement.

•

If researchers have any questions regarding proper use of PPE in their specific
situation, they should follow standard procedures for biosafety as outlined in our
“Biosafety Training for BSL-1 and BSL-2 laboratories.” This includes not wearing gloves
outside of the laboratory.

•

If there are any questions regarding proper BSL-1 or BSL-2 training or use, please
review your learning central training or contact the Office of Research Biosafety Team
(TMuller@salud.unm.edu or NDonart@salud.unm.edu).

Clinical Research and Related Human Participant Research
We appreciate everyone’s heroic efforts to move study visits and assessments to remote and
virtual platforms to the extent possible. When possible, please continue conducting study visits
and assessments virtually. We recognize that some studies require in-person study
assessments and procedures (imaging, blood draws, physical exams, etc.) that need to be restarted. We will allow an incremental increase in the recruitment of new study participants in a
manner that attempts to reduce the risk of spreading infection in order to protect study and
clinical staff, study participants, and others as appropriate.
•

The possibility of COVID-19 infection will still be present after resuming research
operations. This is part of the “new normal.” Investigators and the HRRC should reevaluate research protocols and develop plans to manage.

•

Studies with in-person procedures that were originally considered minimal risk (e.g.,
interviews, focus groups, blood draws, etc.) may need re-consideration as greater than
minimal risk, due to the risk of COVID-19 infection.

•

The risk-benefit analysis for a protocol may have shifted. The adequacy of provisions to
minimize risk, to monitor safety, and to protect privacy and confidentiality may need to
be re-evaluated.

•

It may no longer be feasible to resume certain research as originally proposed and
approved due to facility shut-downs, supply shortages, furloughs, etc.

•

Please continue the non-contact screening protocol prior to all in-person research
visits, to assess for active symptoms of acute respiratory infection possibly related to
COVID-19.

•

This may be accomplished by communication with participants, care providers,
screening surveys, or other options.

•

Participants should be screened for COVID-19 symptoms in UNM Hospital prior to
entering any other areas on campus. They may also be screened prior to entrance to
the building, and family members may not be allowed to accompany the participant to
the visit.

•

If family members are required participants in in-person study activities (e.g., pediatric
studies), they must also be screened as above.

•

If in-person visits are required and a suitable location for the visits and activities is
available, continue to reduce exposure risk with the following steps:

•

Social distancing (minimum of 6’).

•

Reduce the number of people in an exam room to no greater than 2 at a time.

•

Include a barrier between research personnel and participants.

•

Minimize the number of staff who have “hands on” contact with study participants.

•

Wear personnel protective equipment (PPE) including gloves, masks and, if
appropriate, gowns.

•

Wash your hands before and after contact with participants.

•

Disinfect surfaces and equipment in the location of the visit before and after each
participant visit with recommended products. Consult the EPA List N for approved
disinfectants against SARS-CoV-2.

•

If research involves clinical areas, all regulations about the use of clinical space must
be followed and study staff must coordinate visits with these areas prior to scheduling
the in-person study visit and associated clinical activities.

•

Studies that conduct quality assurance monitoring of their own or participating sites
should consider how to adapt monitoring procedures to occur remotely.

•

Possibilities might include email, conference calls, video conferencing, and approved
secure platforms for exchange of files and data.

•

Any reduction in the nature or frequency of HRRC-approved monitoring procedures
should be approved in advance by the HRRC.

•

Outside monitors are still prohibited from coming on-campus at this time.

•

Please note that some study sponsors will not approve re-initiation of study visits and
recruitment, and some hospital services will not yet be available for research use.

Community Based Research Work
For personnel engaged in community-based research (research outside of the UNM Campus),

personnel will continue to conduct research through the use of electronic methods - Zoom,
phone calls, emails - to mitigate the chance of cross contamination between communities.
Travel to areas or communities who have not met the public health guidelines for reopening in
New Mexico will not be permitted (there is more guidance on this issue to come). Essential, oncampus activities will be minimized to the extent possible, while still advancing research efforts.
When in-person visits are necessary and a location is available that meets the public health
guidelines for reopening in New Mexico, continue to reduce exposure risk with the following
steps:
•

Wear a cloth mask at all times.

•

Maintain physical distancing (minimum of 6’).

•

Reducing the number of people in a room to no greater than 3 at a time.

•

Minimize the number of staff who have “hands on” contact with study participants.

•

Wash your hands before and after contact with participants.

Health and Safety
A significant increase in the population density in our buildings comes with health risks, and we
will need to be more vigilant than ever in mitigating these risks, as follows:
•

If a worker feels any signs of illness, no matter how mild, they must not perform work of
any kind in lab areas.

•

All personnel working or learning at UNMHSC who test or have tested positive for
COVID-19 at an outside facility must self-report the positive COVID-19 test result to the
appropriate UNMHSC department, immediately stop working in lab areas and on site,
and enter quarantine at home.

•

Avoid social interactions and exposures to potentially contaminated surfaces during
commutes, building entry and exit, elevator rides, movement in stairways, and
bathroom breaks.

•

Avoid common areas for lunch or coffee breaks unless you are alone or seated at
distant tables; otherwise find an isolated location in lobby areas or outside the building.

•

To reduce viral transmission between shifts, all labs should prepare spray bottles
containing 10% bleach solutions (0.5% sodium hypochlorite), , >0.5 hydrogen
peroxide based disinfectants (e.g., PREempt™) or ethanol/quaternary
ammonium disinfectants (Virex®, QUATRICIDE®, Lysol® Disinfecting Wipes) to
disinfect bench surfaces, door knobs, and equipment surfaces frequently, and at the
beginning and end of a shift.

•

After applying bleach to metal surfaces (1-minute wet contact time), surfaces should be
wiped down with water or 70% isopropanol to prevent metal corrosion.

•

Wash hands with soap regularly throughout the day, especially after removing gloves.

•

Remove gloves before leaving the lab.

•

Gloves should not be worn in hallways, elevators, or offices.

•

If staff must use gloves outside the lab to avoid touching shared surfaces, then use
different colored (clean) gloves to differentiate them from lab-use gloves.

•

1-3 people per elevator; wait for the next one if occupied.

•

Bathrooms should be limited to 50% occupancy; leave and return later if you find that a
bathroom is occupied by 50% or more.

•

When physical distancing is not possible (lab or office spaces with corridors less than 6
feet wide), seek an alternate route or make your presence known verbally from 6 feet
away.

Travel
Employees must self-report all out-of-county and out-of-state travel, and they must self-isolate
for 14 days if advised by the University when self-reporting.
Avoid unnecessary business or personal travel. Staff who have participated in personal travel
should take precautions prior to and when returning to work. If travel is required, self-report and
follow instruction from the University upon self-reporting.
Staff who have received visitors to their personal households should take precautions prior to
and when returning to work.

Animal Resource Facility Research
The ongoing ethical care and maintenance of animal populations and/or ensuring the ethical
care and conduct of research with animal subjects remains an essential function of the ARF. As
research operations involving animals resumes, please consider the following:
•

Research involving animals should be limited to the ARF facility, unless resources
required for such research is only available within the PI laboratory and approval for the
function is granted by both the IACUC and the initial phase laboratory inspections.

•

The possibility remains that a new phase of public health emergency may create a
renewed need to shelter-in-place.

•

Prior to ordering/obtaining new animals, researchers should consider the ramifications
on their animal subjects of another rapid ramp-down.

•

Many animal research studies are longitudinal and entail regular follow up of wellcharacterized cohorts. Delays in regular follow up may lead to data loss, loss of the
cohort, and in some instances a failed study (i.e., lack of requisite data to address
specific aims) after many years of investment.

•

Since space is limited to 25-50 % occupancy, priority may be given to resuming these
projects over starting new projects.

Sources
CDC Infection Control and Disinfection Guidelines
CDC Cloth Mask Guidance
EPA Registry of COVID-19 Disinfectants
CDC Guideline for Disinfection and Sterilization in Healthcare Facilities
Please note that the University of New Mexico also has a webpage that is updated frequently, if
you have specific questions regarding the University’s response to the ongoing situation.
The Health Sciences Center Office of Research website contains information on specific
research-related updates, including the Research Continuity Guidelines for both Laboratories &
Research Facilities and Clinical Trial Research Faculty & Staff.

